Merrill Lynch and Deutsche Bank initiates coverage on recent IPO Cadence Pharmaceuticals (Nasdaq: CADX) with Buy ratings.

This article: 87 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE